Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-Intensity Focused Ultrasonic Ablation of the Centromedian Thalamic Nucleus for Treatment of Medically Refractory Generalized Epilepsy

NCT07803692 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT07803692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07803692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-Intensity Focused Ultrasonic Ablation of the Centromedian Thalamic Nucleus for Treatment of Medically Refractory Generalized Epilepsy
Lead sponsor
Oregon Health and Science University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 28, 2027
Completion date
June 30, 2031
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic generalized epilepsy